Phase 1 trial of 17-AAG in patients with relapsed and refractory multiple myeloma (MM) No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2005 ASCO Annual ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results